533 Pill - yellow capsule/oblong, 13mm
Pill with imprint 533 is Yellow, Capsule/Oblong and has been identified as Minocycline Hydrochloride Extended-Release 90 mg. It is supplied by Zydus Pharmaceuticals (USA) Inc.
Minocycline is used in the treatment of Bacterial Infection; Acne; Bartonellosis; Bullous Pemphigoid; Actinomycosis and belongs to the drug class tetracyclines. There is positive evidence of human fetal risk during pregnancy. Minocycline 90 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 533
Minocycline Hydrochloride Extended-Release
- Imprint
- 533
- Strength
- 90 mg
- Color
- Yellow
- Size
- 13.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Tetracyclines
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Zydus Pharmaceuticals (USA) Inc.
- Manufacturer
- Cadila Healthcare Limited
- National Drug Code (NDC)
- 70771-1156
- Inactive Ingredients
-
silicon dioxide,
D&C Yellow No. 10,
ferric oxide red,
ferric oxide yellow,
hypromelloses,
lactose monohydrate,
magnesium stearate,
polyethylene glycol 3350,
titanium dioxide,
triacetin
Note: Inactive ingredients may vary.
Related images for "533"
More about minocycline
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (563)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: tetracyclines
- Breastfeeding
- En español
Patient resources
- Minocycline drug information
- Minocycline (Intravenous) (Advanced Reading)
- Minocycline Capsules and Tablets
- Minocycline Extended-Release Tablets
Other brands
Minocin, Emrosi, Solodyn, Dynacin, ... +3 more
Professional resources
- Minocycline monograph
- Minocycline (EENT) (AHFS Monograph)
- Minocycline (FDA)
- Minocycline Capsules (FDA)
- Minocycline Extended Release Tablets (FDA)
Other brands
Minocin, Solodyn, Minocin for Injection, Minolira, Ximino
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.